Tau protein phosphorylation at Thr175 initiates fibril formation via accessibility of the N-terminal phosphatase-activating domain

J Neurochem. 2020 Nov;155(3):313-326. doi: 10.1111/jnc.14942. Epub 2019 Dec 30.

Abstract

One of the neuropathological hallmarks of the tauopathies is the formation of neuronal cytoplasmic inclusions and fibrils of microtubule-associated tau protein (tau). The phosphorylation of Thr175 of tau (pThr175 tau) appears to be sufficient for fibril formation in vitro and in vivo, but the mechanism by which this initiates fibril formation is unknown. Using transient transfections of tau mutants into HEK293T cells, we determined that the phosphorylation of Thr175 leads to exposure of the tau N-terminal phosphatase-activating domain (PAD). The exposed PAD is known to interact with protein phosphatase-1 (PP1) resulting in glycogen synthase kinase 3β (GSK3β) activation. In vivo, a single traumatic controlled cortical injury in rats also resulted in the phosphorylation of Thr175 and increased exposure of tau PAD followed by pathological tau fibril formation. Taken together, these data suggest that neurotoxicity may be precipitated by phosphorylation at Thr175 and subsequent tau PAD exposure, GSK3β activation and tau fibril formation. Cover Image for this issue: doi: 10.1111/jnc.14767.

Keywords: amyotrophic lateral sclerosis; chronic traumatic encephalopathy; frontotemporal dementia; microtubule associated protein tau; phosphatase-activating domain.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amyloid / metabolism*
  • Animals
  • Female
  • Glycogen Synthase Kinase 3 beta / metabolism
  • HEK293 Cells
  • Humans
  • Phosphoric Monoester Hydrolases / metabolism*
  • Phosphorylation / physiology
  • Rats
  • Rats, Sprague-Dawley
  • Threonine / metabolism*
  • tau Proteins / metabolism*

Substances

  • Amyloid
  • MAPT protein, human
  • tau Proteins
  • Threonine
  • GSK3B protein, human
  • Glycogen Synthase Kinase 3 beta
  • Phosphoric Monoester Hydrolases